USANA Q1 2025 presentation highlights: Revenue grows despite profit decline as Hiya integration continues

Introduction & Market Context

USANA Health Sciences (NYSE:USNA) recently presented its Q1 2025 investor overview, highlighting the company’s strategic pivot toward the children’s wellness market through its Hiya Health acquisition while navigating earnings pressure. The Salt Lake City-based nutritional and personal care products company reported revenue growth but faced declining profits as it continues integrating its recent acquisition.

Following the April 23, 2025 earnings release, USANA’s stock rose 4.72% to close at $25.39, reflecting investor optimism about the company’s strategic direction despite mixed financial results. According to the earnings report, USANA posted Q1 revenue of $250 million, exceeding analyst expectations of $243.15 million, while adjusted EPS of $0.73 fell short of the $0.80 forecast.

Company Profile & Business Model

USANA develops and manufactures science-based nutritional and personal care products sold through direct sales and direct-to-consumer channels. Founded in 1992, the company now employs approximately 1,700 full-time staff and generated $876 million in trailing twelve-month revenue as of Q1 2025.

The company’s product portfolio remains heavily weighted toward nutritional supplements, which account for 87% of sales, with skincare and foods each representing 6% of revenue. Geographically, Greater China dominates USANA’s business at 51% of sales, followed by Americas & Europe (23%), Southeast Asia Pacific (17%), and North Asia (9%).

USANA’s direct selling model provides several operational advantages, including relatively low incremental costs to add new customers, strong cash generation potential, and the ability to expand into new markets with moderate investment. The company defines its customer base as "Active Customers," comprising both Associates (independent distributors who purchase products for personal use and resale) and Preferred Customers (who purchase strictly for personal use).

Strategic Acquisition: Hiya Health Products

A central focus of USANA’s presentation was its recent acquisition of Hiya Health Products, a fast-growing children’s health and wellness company founded in 2020. This strategic move represents a significant shift for USANA, expanding its direct-to-consumer presence beyond its traditional direct selling model.

The Hiya acquisition offers USANA several strategic benefits, including entry into the growing children’s health market, channel expansion into direct-to-consumer wellness, potential financial profile strengthening, opportunities for synergies, and expanded U.S. business presence. Hiya’s subscription-based business model provides predictable revenue streams and stronger customer relationships, which USANA believes will complement its existing operations.

Hiya’s products focus on "better-for-you" children’s health and wellness items with clean ingredients that appeal to health-conscious parents while maintaining taste and engagement features that appeal to children. The company employs diverse marketing channels including social media platforms, influencer partnerships, podcasts, and direct mail to reach its target audience.

Financial Performance

USANA’s Q1 2025 financial results showed revenue growth but declining profitability compared to the same period last year. Net sales increased to $249.5 million from $227.8 million in Q1 2024, representing a 9.5% year-over-year increase. However, net earnings declined to $9.3 million from $16.5 million, a 43.8% decrease, while diluted EPS fell to $0.49 from $0.86.

The significant gap between GAAP EPS ($0.49) and adjusted EPS ($0.73) reflects costs associated with the Hiya acquisition and integration. The company’s reconciliation shows adjustments for transaction costs, amortization of intangible assets, and other acquisition-related expenses.

Looking ahead, USANA provided fiscal year 2025 guidance projecting net sales between $920 million and $1 billion, net earnings between $29 million and $41 million, and adjusted diluted EPS between $2.35 and $3.00.

International Expansion & Growth Strategy

USANA currently operates in 25 markets globally, with approximately 86% of net sales generated outside the United States. The company expanded into India in late 2023 and continues to focus on international growth opportunities, particularly in Greater China.

The presentation highlighted USANA’s evolving geographic sales mix over time, showing increased diversification across regions. While the earnings article reported strong 64% year-over-year sales growth in Mainland China, the presentation data indicated some challenges in regional performance across the broader Asia Pacific region.

USANA’s global growth strategy centers on three pillars: active customer growth, international expansion, and strategic collaborations and acquisitions. The company sees significant opportunity in the global vitamins and supplements market, which is projected to grow from $128 billion in 2021 to $174 billion by 2028.

Balance Sheet & Capital Allocation

USANA maintained a stable balance sheet with $180 million in cash as of Q1 2025, though this represents a significant decrease from $330 million at the end of 2023, largely due to the Hiya acquisition. The company’s total debt stood at $23 million, up from virtually zero debt in previous years.

Free cash flow generation has declined from $145 million (13% margin) in 2020 to $49 million (6% margin) in the trailing twelve months ending Q1 2025. This trend reflects both the company’s investment in growth initiatives and the integration costs associated with the Hiya acquisition.

USANA’s capital allocation priorities include internal investment for organic growth, acquisitions and partnerships, and share repurchases. In 2024, the company allocated $203 million to acquisitions (primarily Hiya) and $9 million to share repurchases. In the first quarter of 2025, USANA continued its share repurchase program, spending $12 million.

Forward-Looking Statements

USANA outlined several growth initiatives for the future, particularly focused on expanding Hiya’s product portfolio, distribution channels, and geographic reach. The company plans to leverage its international expertise to bring Hiya products to new markets while developing new children’s wellness products and exploring brand collaborations.

Management remains confident in USANA’s long-term growth prospects despite near-term earnings pressure. The company’s strategic pivot toward children’s wellness through the Hiya acquisition represents a significant opportunity to diversify its business model and tap into growing consumer demand for premium children’s nutritional products.

As USANA continues integrating Hiya and executing its international expansion strategy, investors will be watching closely to see if the company can translate its revenue growth into improved profitability in the coming quarters.

Full presentation:

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.